NewsBenzinga美国食品和药物管理局（FDA）批准了QIAGEN的革兰氏阴性 QIAstat-Dx 血流板，加入革兰氏阳性和真菌板，覆盖33种病原体靶标和28种抗药性标记。 美国食品和药物管理局（FDA）批准了QIAGEN的革兰氏阴性 QIAstat-Dx 血流板，加入革兰氏阳性和真菌板，覆盖33种病原体靶标和28种抗药性标记。 Benzinga 2026.09.28 07:10 (GMT+0) Open on Benzinga Other news QCP: Bitcoin Faces Dual Pressure from Geopolitics and Macro Data, Key Support Levels in Focus Is CrowdStrike Stock Outperforming the S&P 500? Solana Developers Say “No Alpenrush” as Alpenglow Mainnet Launch Rumors Collapse Compound Foundation accused of improperly using 8.42 million DAI reserves Micron Heads Into Earnings With Memory Prices Still Climbing and Supply Nowhere Near Enough Piper Sandler Maintains Overweight on Tyler Technologies, Lowers Price Target to $450
